Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of vildagliptin (Galvus) on beta-cell function
2008-004231-38Phase 4Active
- Sponsor
- St. Josef-Hospital Bochum
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by St. Josef-Hospital Bochum. Primary endpoint: Change in beta-cell function. Started Aug 2008; status: active.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-004231-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004231-38.